Literature DB >> 6604692

Cellular bases of the production of and response to interleukin-2 in man: role of autologous rosette-forming T-cell subsets defined with monoclonal antibodies.

E Fishbein, J Alcocer-Varela, D Alarcón-Segovia.   

Abstract

In this paper we present experiments that indicate that, in man, most T-cell subpopulations produce interleukin-2 (IL-2), but that the main cell subpopulation which produces it, both upon activation with phytohaemagglutinin or in autologous mixed lymphocyte cultures, is that of autologous rosette-forming (Tar) T4+ T cells. Conversely, the main IL-2-responding T-cell subpopulation is that composed of T cells depleted of Tar (T-Tar) that are T8+. IL-2 was also found to be more effectively produced by Tar cells that do not bind peanut agglutinin (PNA) than by those that do. The PNA-T4+Tar cells were also found to respond best to interleukin-1 (IL-1).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604692      PMCID: PMC1454336     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

Review 1.  A suggested mechanism for T lymphocyte activation: implications on the acquisition of functional reactivities.

Authors:  E L Larsson; A Coutinho; C Martinez
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

2.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

3.  Autologous mixed lymphocyte reaction in man. II. Autoreactive and alloreactive cells belong to two different T cell subsets.

Authors:  C Fournier; J Charreire
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

4.  Functional analysis of human T cell subsets defined by monoclonal antibodies. I. Collaborative T-T interactions in the immunoregulation of B cell differentiation.

Authors:  Y Thomas; J Sosman; O Irigoyen; S M Friedman; P C Kung; G Goldstein; L Chess
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

5.  Cytokine-dependent thymocyte responses: characterization of IL 1 and IL 2 target subpopulations and mechanism of action.

Authors:  P J Conlon; C S Henney; S Gillis
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

6.  Functional heterogeneity of helper T cells: two distinct helper T cells are required for the production of T cell growth factor.

Authors:  E L Larsson
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

7.  Self recognition by autologous mixed lymphocyte reaction-primed cells.

Authors:  K Tomonari; A Wakisaka; M Aizawa
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

8.  Human post-thymic precursor cells in health and disease. I. Characterization of the autologous rosette-forming T cells as post-thymic precursors.

Authors:  R Palacios; D Alarcón-Segovia; L Llorente; A Ruíz-Arguelles; E Díaz-Jouanen
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

9.  Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.

Authors:  J Alcocer-Varela; D Alarcón-Segovia
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

10.  Functional analysis of the defective T cell regulation of the antigen-specific PFC response in SLE patients: differentiation of suppressor precursor cells to suppressor effector cells.

Authors:  C J Heijnen; K H Pot; L Kater; H C Kluin-Nelemans; F Uytdehaag; R E Ballieux
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

View more
  12 in total

1.  A defect in immunoregulatory synovial fluid T cells in Behçet's syndrome.

Authors:  J Alcocer-Varela; A Laffon; C Abud-Mendoza; D Alarcon-Segovia
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

2.  Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor) expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro.

Authors:  K Y Tsang; H H Fudenberg; G M Galbraith; R P Donnelly; L R Bishop; W R Koopmann
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

3.  Effect of the new immunoregulator AS-101 on in vitro functions of mononuclear cells from patients with systemic lupus erythematosus.

Authors:  J Alcocer-Varela; D Alarcon-Segovia; B Sredni; M Albeck
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

4.  Differences in the kinetics of the autologous mixed lymphocyte reaction between the various connective tissue diseases.

Authors:  A Laffón; J Alcocer-Varela; D Alarcón-Segovia
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

5.  Natural killer cell-mediated activity in mixed connective tissue disease and its response to induction by interleukin-2.

Authors:  R González-Amaro; J Alcocer-Varela; E Martínez-Cordero; D Alarcón-Segovia
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

6.  Differences in the production of and/or the response to interleukin-2 by T lymphocytes from patients with the various connective tissue diseases.

Authors:  J Alcocer-Varela; A Laffón; D Alarcón-Segovia
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

7.  Interleukin 2 production and its relationship with T lymphocyte subsets in patients with obstructive jaundice.

Authors:  H Li; S T Xiong; S X Zhang; S B Liu; Y Luo; P Zou; J P Xiang
Journal:  J Tongji Med Univ       Date:  1992

8.  Immunoregulatory circuits in the acquired immune deficiency syndrome and related complex. Production of and response to interleukins 1 and 2, NK function and its enhancement by interleukin-2 and kinetics of the autologous mixed lymphocyte reaction.

Authors:  J Alcocer-Varela; D Alarcon-Segovia; C Abud-Mendoza
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

9.  Mechanisms of immunosuppression associated with severe nonthermal traumatic injuries in man: production of interleukin 1 and 2.

Authors:  M L Rodrick; J J Wood; J B O'Mahony; C F Davis; J T Grbic; R H Demling; N M Moss; I Saporoschetz; A Jordan; P D'Eon
Journal:  J Clin Immunol       Date:  1986-07       Impact factor: 8.317

10.  Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset.

Authors:  C Saltini; J R Spurzem; J J Lee; P Pinkston; R G Crystal
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.